24 May 2013
Keywords: rxkinetix, starts, phase, ii, mucositis, trials, colorado
Article | 27 January 2003
Colorado, USA-based RxKinetix has begun patient enrollment in a PhaseII clinical trial of RK-0202 in oral mucositis, a painful and
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 January 2003
23 May 2013
© 2013 thepharmaletter.com